Cells lacking CIP1/WAF1 genes exhibit preferential sensitivity to cisplatin and nitrogen mustard

Oncogene

Volumn 14, Issue 18, 1997, Pages 2127-2136

  Fan, Saijun ^a,b   Chang, Johnny K ^a   Smith, Martin L ^a   Duba, Diane ^a   Fornace Jr , Albert J ^a   O'Connor, Patrick M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

Cell cycle checkpoints; Chemosensitivity; CIP1 WAF1; DNA repair; p53; Radiation

Indexed keywords

CHLORMETHINE; CISPLATIN; DOXORUBICIN; PACLITAXEL; PROTEIN P21; PROTEIN P53; VINCRISTINE;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; COLON CANCER; CONTROLLED STUDY; DNA CROSS LINKING; DNA REPAIR; EMBRYO; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; IONIZING RADIATION; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; WART VIRUS;

ANIMALIA; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; MURINAE;

EID: 0030913266     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201052     Document Type: Article

References (40)

1. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T and Hannon G. (1995). Nature, 377, 552-557.
2. Chen I-T, Smith ML, O'Connor PM and Fornace Jr AJ. (1995). Oncogene, 11, 1931-1937.
3. Crook T, Wrede D and Vousden KH. (1991). Oncogene, 6, 873-875.
4. Dabholkar M, Eastman A and Reed E. (1990). Carcinogenesis, 11, 1761-1764.
5. Deng C, Zhang P, Harper JW, Elledge SJ and Leder P. (1995). Cell, 82, 675-684.
6. Dulic V, Kaufmann WK, Wilson SJ, Tlsty TD, Lees E, Harper JW, Elledge SJ and Reed SI. (1994). Cell, 76, 1013-1023.
7. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Lin D, Mercer WE, Kinzler KW and Vogelstein B. (1993). Cell, 75, 817-825.
8. El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, Wiman KG, Mercer WE, Kastan ME, Kohn KW, Elledge SJ, Kinzler KW and Vogelstein B. (1994). Cancer Research, 54, 1169-1174.
9. Fan S, El-Deiry WS, Bae I, Freeman J, Jondle D, Bhatia K, Fornace Jr AJ, Magrath I, Kohn KW and O'Connor PM. (1994). Cancer Research, 54, 5824-5830.
10. Fan S, Smith ML, Rivet DJ, Duba D, Zhan Q, Kohn KW, Fornace Jr AJ and O'Connor PM. (1995). Cancer Research, 55, 1649-1654.
11. Ford JM and Hanawalt PC. (1995). Proc. Natl. Acad. Sci. (USA), 92, 8876-8880.
12. Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ. (1993). Cell, 75, 805-816.
13. Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, Dobrowolski S, Bai C, Connell-Crowley L, Swindell E, Fox MP and Wei N. (1995). Mol. Biol. Cell., 6, 387-400.
14. Hawkins DS, Demers GW and Galloway DA. (1996). Cancer Research, 56, 892-898.
15. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW. (1991). Cancer Research, 51, 6304-6311.
16. Li R, Waga S, Hannon GJ, Beach D and Stillman B. (1994). Nature, 371, 534-537.
17. Lowe SW, Ruley HE, Jacks T and Houseman DE. (1993). Cell, 74, 957-967.
18. McDonald III EE, Wu GS, Waldman T and El-Deiry WS. (1996). Cancer Research, 56, 2250-2255.
19. O'Connor PM. (1996). Anticancer Drugs, 7, 135-141.
20. O'Connor PM and Fan S. DNA damage checkpoints: Implications for cancer therapy. In: Progress in Cell Cycle Research. Eds. Meijer L, Guidet S and Vogel L. Plenum Press, New York, in press.
21. O'Connor PM, Jackman J, Jondle D, Bhatia K, Magrath I and Kohn KW. (1993). Cancer Research, 53, 4776-4780.
22. O'Connor PM, Wasserman K, Sarang M, Magrath I, Bohr VA and Kohn KW. (1991). Cancer Research, 51, 6550-6557.
23. Pan Z-Q, Reardon JT, Li L, Flores-Rozas H, Legerski R, Sancar A and Hurwitz J. (1995). J. Biol. Chem., 270, 22008-22016.
24. Protic M, Roilides E, Levine AS and Dixon K. (1988). Somat. Cell Mol. Genet., 14, 351-357.
25. Robbins JH. (1974). Ann. Int. Med., 80, 221-248.
26. Sheikh MS, Chen YQ, Smith ML and Fornace Jr AJ. (1997). Oncogene, in press.
27. Shivji MK, Grey SJ, Strausfeld UP, Wood RD and Blow JJ. (1994). Curr. Biol., 4, 1062-1068.
28. Smith ML, Chen IT, Zhan Q, Bae I, Chen CY, Gilmer TM, Kastan MB, O'Connor PM and Fornace Jr AJ. (1994). Science, 266, 1376-1380.
29. Smith ML, Chen I, Zhan Q, O'Connor PM and Fornace Jr AJ. (1995). Oncogene, 10, 1053-1059.
30. Smith ML, Kontny HU, Zhan Q, Sreenath A, O'Connor PM and Fornace Jr AJ. (1996). Oncogene, 13, 2255-2263.
31. Torres-Ramos CA, Yoder BL, Burgers PM, Prakash S and Prakash L. (1996). Proc. Natl. Acad. Sci. USA, 3, 9676-9681.
32. Umar A, Buermeyer AB, Simon JA, Thoma DC, Clark AB, Liskay RM and Kunkel TA. (1996). Cell, 87, 65-73.
33. Waga S, Hannon GJ, Beach D and Stillman B. (1994). Nature, 369, 574-578.
34. Waldman T, Kinzler KW and Vogelstein B. (1995). Cancer Research, 55, 5187-5190.
35. Waldman T, Lengauer C, Kinzler KW and Vogelstein B. (1996). Nature, 381, 713-716.
36. Wang Q, Fan S, Eastman A, Worland PJ, Sausville EA and O'Connor PM. (1996). J. Natl. Cancer Instit., 88, 956-965.
37. Wang XW, Forrester K, Yeh H, Feitelson MA, Gu JR and Harris CC. (1994). Proc. Natl. Acad. Sci. (USA), 91, 2230-2234.
38. Wang XW, Yeh H, Schaeffer L, Roy R, Moncollin V, Egly JM, Wang Z, Freidberg EC, Evans MK, Taffe BG, et al. (1995). Nature Genet., 10, 188-195.
39. Werness BA, Levine AJ, Howley PM. (1990). Science, 248, 76-79.
40. Zhen W, Link CJ, O'Connor PM, Reed E, Parker R, Howell SB and Bohr VA. (1992). Mol. Cell. Biol., 12, 3689-3698.